FAUCI Act

Crime and Law Enforcement
senate
house
president

Introduced on May 1, 2024 by James David Vance

Legislation Details

  • Prohibits former employees of certain health agencies from serving on boards of entities involved in drug, biological product, or device development and research within 8 years of their service ending.
  • Defines “covered health agencies” to include the National Institutes of Health, the Food and Drug Administration, and the Centers for Disease Control and Prevention.
  • Defines “top official” as any executive branch employee at or above GS-13 or anyone with authority over drug, biological product, or device use authorization.
  • Imposes penalties for former covered health agency employees who profit from a drug, biological product, or device they were involved in approving for grant applications, including a $250,000 civil penalty and imprisonment.
  • Amends penalties section to include violations of the new prohibitions.
  • Applies the new rules to individuals whose service ends after the enactment of the Act, with a special compliance period for those whose service ended before enactment.
  • Prohibits top officials from applying for patents related to their work during and after their employment, with specific rules for inventions made during and outside of their official duties.
  • Requires top officials and their spouses to disclose any ownership or interest in relevant patents within set timeframes after the Act’s enactment or after becoming a top official.

Last updated 10/7/2024